157 related articles for article (PubMed ID: 22513478)
1. CASP8 -652 6N del polymorphism and cancer risk: a meta-analysis of 30 case-control studies in 50,112 subjects.
Zhang F; Yang Y; Guo C; Wang Y
Mutagenesis; 2012 Sep; 27(5):559-66. PubMed ID: 22513478
[TBL] [Abstract][Full Text] [Related]
2. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
3. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
4. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
Chatterjee K; Williamson AL; Hoffman M; Dandara C
J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
[TBL] [Abstract][Full Text] [Related]
5. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
[TBL] [Abstract][Full Text] [Related]
6. Functional variants in cell death pathway genes and risk of pancreatic cancer.
Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
[TBL] [Abstract][Full Text] [Related]
7. CASP8 -652 6N del polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.
Peng Q; Lao X; Tang W; Chen Z; Li R; Wang J; Deng Y; Li T; Qin X; Li S
PLoS One; 2014; 9(2):e87925. PubMed ID: 24498403
[TBL] [Abstract][Full Text] [Related]
8. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 gene polymorphisms and cancer susceptibility: a meta-analysis.
Wang X; Li J; Xie W; Zhang W; Chang Y
Neoplasma; 2013; 60(4):459-67. PubMed ID: 23581420
[TBL] [Abstract][Full Text] [Related]
10. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with risk of coal workers' pneumoconiosis.
Ni C; Ye Y; Wang M; Qian H; Song Z; Jia X; Zhou J
J Toxicol Environ Health A; 2009; 72(11-12):712-6. PubMed ID: 19492233
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk.
Du H; Song GX; Fang MZ; Shu YQ; Zhao X; Zhu LJ
J Biomed Res; 2019 Jun; 33(3):173-180. PubMed ID: 30057371
[TBL] [Abstract][Full Text] [Related]
12. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
Li Z; Wang J; Wang F; Ma Z; Yu Z
Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
[TBL] [Abstract][Full Text] [Related]
13. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis.
Hu Z; Li X; Qu X; He Y; Ring BZ; Song E; Su L
Carcinogenesis; 2010 Apr; 31(4):643-7. PubMed ID: 20089604
[TBL] [Abstract][Full Text] [Related]
14. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
[TBL] [Abstract][Full Text] [Related]
15. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck.
Li C; Lu J; Liu Z; Wang LE; Zhao H; El-Naggar AK; Sturgis EM; Wei Q
Cancer Prev Res (Phila); 2010 Feb; 3(2):246-53. PubMed ID: 20086182
[TBL] [Abstract][Full Text] [Related]
16. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
Hu Z; Li X; Yuan R; Ring BZ; Su L
Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
[TBL] [Abstract][Full Text] [Related]
18. Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer.
Kesarwani P; Mandal RK; Maheshwari R; Mittal RD
BJU Int; 2011 Feb; 107(3):471-6. PubMed ID: 20804486
[TBL] [Abstract][Full Text] [Related]
19. Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.
Zhang CD; Li HT; Liu K; Lin ZD; Peng QL; Qin X; He M; Wu H; Mo ZN; Yang XL
Asian Pac J Cancer Prev; 2014; 15(18):7713-8. PubMed ID: 25292051
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
